Medical Bionic Implant/Artificial Organs Market Research Report – Forecast to 2027

Medical Bionic Implant/Artificial Organs Market Research Report: By Technology (Mechanical, Electronic Bionics), by Product (Vision, Ear, Orthopedic, Heart, Neural/Brain), by Fixation (Implantable, Externally Worn), by End-User – Global Forecast Till 2027

ID: MRFR/MED/4593-HCR | February 2021 | Region: Global | 100 pages

Please note that the assessment period of report has been updated from 2018-2023 to 2020-2027. Cordially fill the sample form for updated data

Market Scenario


The global medical bionic implant/artificial organs market is expected to gain prominence over the forecast period (2018–2023). It is estimated that the medical bionic implant market is expected to register a CAGR of 7.0% during the forecast period of 2018–2023.


Bionic implants are artificially engineered devices that are implanted into a human to replace a natural organ. The main purpose of bionic implants is to provide life support to prevent imminent death while awaiting a transplant and improve a patient's ability to interact socially.


It is observed that the increasing cases of organ failure have increased the demand for replaceable organs, which is propelling the medical bionic implant/artificial organs market to a great extent. According to the statistics suggested by the National Kidney Foundation, 2016  around 121,678 people were waiting for lifesaving organ transplants in the in the United States. It is also reported that in 2014, 17,107 kidney transplants took place in the U.S. The incidences of organ failure are found to be more common in the aging population, as it is more vulnerable towards health issues such as ophthalmic diseases, gastrointestinal problems, orthopedic diseases, cancer, and others.


Various other factors such as technological advancements, increasing accidents and injuries, improving regulatory framework, increasing government assistance, and increasing prevalence of eye diseases are continuously contributing to the growth of the global medical bionic implant/artificial organs market.


Despite these drivers, there are some issues associated with the medical bionic implant/artificial organs market. Lack of skilled professionals, the high cost of devices, fear of malfunction of devices, and poor healthcare system in low and middle-income countries may hamper the growth of the market to an extent.


Regional Market Summary


The Americas dominates the medical bionic implant/artificial organs market owing to the introduction of advanced medical bionic implants by major market players. On November 02, 2017, Second Sight Medical Products, Inc., a U.S. based company, received the U.S. FDA approval to initiate the Orion Cortical Visual Prosthesis System (Orion) feasibility clinical study. In 2013, the company won the FDA approval for the Argus II retinal prosthesis system.


Europe holds the second position in the medical bionic implant/artificial organs market. It is expected that the government support towards research and development expenditure and increasing cases of organ failure and related complications are likely to drive the European market.


Asia Pacific is the fastest growing medical bionic implant/artificial organs market owing to a huge patient pool, increasing demand for advanced treatments, and development in the healthcare technology. Healthcare expenditure is found to be improving in various Asia Pacific regions. According to the data suggested by Australian Institute of Health and Welfare during the year 2015 to 2016, the total health expenditure was USD 170.4 billion, i.e., 3.6% higher than the expenditure during 2014 to 2015.


The Middle East and Africa holds the lowest share of the global market due to low development, lack of technical knowledge, and poor medical facilities.


Key Players


Some of key the players in the global medical bionic implant/artificial organs  market are Aleva Neurotherapeutics SA (Switzerland), Biocontrol Medical (Israel), Biomet, Inc. (U.S.), Boston Scientific Corporation (U.S.), Cochlear Ltd. (Australia), Cyberonics, Inc. (U.S.), Ekso Bionics (U.S.), LivaNova PLC (U.K), Medtronic, Inc. (U.S.), NeuroPace, Inc. (U.S.), Orthofix International N.V. (The Netherlands), Ossur (Iceland), Second Sight Medical Products, Inc. (U.S.), and St. Jude Medical, Inc. (U.S.).


Research Methodology


Market Research Future research is conducted by industry experts who offer insight into industry structure, market segmentation, treatment assessment, Competitive Landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analyzing historical trends and current market positions. Furthermore, varying trends of segments and categories geographically presented are studied and are estimated based on the primary and secondary research.



  • Primary Research


The extensive primary research was conducted to gain a deeper insight of the market and the industry performance. In this particular report, we have conducted primary surveys (interviews) with key level executives (VPs, CEOs, Marketing Directors, Business Development Managers, and many more) of major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.



  • Secondary Research


Secondary research was mainly used to collect and identify information useful for an extensive, technical, market-oriented, and commercial study of the medical bionic implant market. It was also used to obtain key information about major players, market classification and segmentation according to industry trends, geographical markets and developments related to the market, and treatment perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company websites, the international organization of chemical manufacturers, some paid databases, and many others.


Segmentation


The global medical bionic implant/artificial organs market is segmented by technology, product, fixation, and end-user.


By technology, the market is classified as mechanical bionics and electronic bionics.


By product, the market is classified as vision bionics, ear bionics, orthopedic bionics, heart bionics, neural/brain bionics, and others. Vision bionics are further segmented as bionic eye and others. Ear bionics are further segmented as cochlear implant, and Bone Anchored Hearing Aid (BAHA). Orthopedic bionics are further segmented as bionic hand, bionic leg, bionic finger, exoskeleton, and electrical bone growth stimulators. The sub-segments of bionic leg include bionic knee and bionic feet. The sub-segments of electrical bone growth stimulators include invasive bone growth stimulators and non-invasive bone growth stimulators. Heart bionics are further segmented as pacemaker, total artificial heart, ventricular assist device, and artificial heart valve. The sub-segments of pacemaker include implantable cardiac pacemaker and external pacemaker. The sub-segments of artificial heart valve include mechanical heart valve and tissue heart valve. Neural/brain bionics are further segmented as deep brain stimulators, vagus nerve stimulators, and spinal cord stimulators.


By fixation, the market is segmented into implantable and externally worn.


By end-user, the market is segmented into hospitals and clinics, research and academic institutes, and others.


Intended Audience



  • Medical Device Companies

  • Research and Development (R&D) Companies

  • Diagnostic Laboratories

  • Government Research Institutes

  • Academic Institutes and Universities



Frequently Asked Questions (FAQ) :


Medical Bionic Implant/Artificial Organs Market is projected to grow at a 7.0% CAGR between 2018-2023.

The Americas is expected to lead the Medical Bionic Implant/Artificial Organs Market.

Improving regulatory framework and increasing injuries and accidents are adding market growth.

High cost and poor healthcare system may limit market growth.

Different strategies used by market players to create a dominance in the Medical Bionic Implant/Artificial Organs Market include mergers and acquisitions, collaborations, product launches, and strategic alliances.

Table Of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Medical Bionic Implant/Artificial Organs Market, By Technology

6.1 Introduction

6.2 Mechanical Bionics

Market Estimates & Forecast, By Region, 2020–2027

Market Estimates & Forecast, By Country, 2020–2027

6.3 Electronic Bionics

Market Estimates & Forecast, By Region, 2020–2027

Market Estimates & Forecast, By Country, 2020–2027

6.4 Others

Chapter 7. Global Medical Bionic Implant/Artificial Organs Market, By Product

7.1 Introduction

7.2 Vision Bionics

7.2.1 Bionic Eye

Market Estimates & Forecast, By Region, 2020–2027

Market Estimates & Forecast, By Country, 2020–2027

7.2.2 Others

Market Estimates & Forecast, By Region, 2020–2027

Market Estimates & Forecast, By Country, 2020–2027

7.3 Ear Bionics

7.3.1 Cochlear Implant

Market Estimates & Forecast, By Region, 2020–2027

Market Estimates & Forecast, By Country, 2020–2027

7.3.2 Bone Anchored Hearing Aid (BAHA)

Market Estimates & Forecast, By Region, 2020–2027

Market Estimates & Forecast, By Country, 2020–2027

7.4 Orthopedic Bionics

7.4.1 Bionic Hand

Market Estimates & Forecast, By Region, 2020–2027

Market Estimates & Forecast, By Country, 2020–2027

7.4.2 Bionic Leg

Market Estimates & Forecast, By Region, 2020–2027

Market Estimates & Forecast, By Country, 2020–2027

7.4.2.1 Bionic Knee

Market Estimates & Forecast, By Region, 2020–2027

Market Estimates & Forecast, By Country, 2020–2027

7.4.2.2 Bionic Feet

Market Estimates & Forecast, By Region, 2020–2027

Market Estimates & Forecast, By Country, 2020–2027

7.4.3 Bionic Finger

Market Estimates & Forecast, By Region, 2020–2027

Market Estimates & Forecast, By Country, 2020–2027

7.4.4 Exoskeleton

Market Estimates & Forecast, By Region, 2020–2027

Market Estimates & Forecast, By Country, 2020–2027

7.4.5 Electrical Bone Growth Stimulators

Market Estimates & Forecast, By Region, 2020–2027

Market Estimates & Forecast, By Country, 2020–2027

7.4.5.1 Invasive Bone Growth Stimulators

Market Estimates & Forecast, By Region, 2020–2027

Market Estimates & Forecast, By Country, 2020–2027

7.4.5.2 Non-Invasive Bone Growth Stimulators

Market Estimates & Forecast, By Region, 2020–2027

Market Estimates & Forecast, By +9+, 2020–2027

7.4.6 Heart Bionics

Market Estimates & Forecast, By Region, 2020–2027

Market Estimates & Forecast, By Country, 2020–2027

7.4.6.1 Pacemaker

Market Estimates & Forecast, By Region, 2020–2027

Market Estimates & Forecast, By Country, 2020–2027

7.4.6.1.1 Implantable Cardiac Pacemaker

Market Estimates & Forecast, By Region, 2020–2027

Market Estimates & Forecast, By Country, 2020–2027

7.4.6.1.2 External Pacemaker

Market Estimates & Forecast, By Region, 2020–2027

Market Estimates & Forecast, By Country, 2020–2027

7.4.6.2 Total Artificial Heart

Market Estimates & Forecast, By Region, 2020–2027

Market Estimates & Forecast, By Country, 2020–2027

7.4.6.3 Ventricular Assist Device

Market Estimates & Forecast, By Region, 2020–2027

Market Estimates & Forecast, By Country, 2020–2027

7.4.6.4 Artificial Heart Valve

Market Estimates & Forecast, By Region, 2020–2027

Market Estimates & Forecast, By Country, 2020–2027

7.4.6.4.1 Mechanical Heart Valve

Market Estimates & Forecast, By Region, 2020–2027

Market Estimates & Forecast, By Country, 2020–2027

7.4.6.4.2 Tissue Heart Valve

Market Estimates & Forecast, By Region, 2020–2027

Market Estimates & Forecast, By Country, 2020–2027

7.4.7 Neural/Brain Bionics

Market Estimates & Forecast, By Region, 2020–2027

Market Estimates & Forecast, By Country, 2020–2027

7.4.7.1 Deep Brain Stimulator

Market Estimates & Forecast, By Region, 2020–2027

Market Estimates & Forecast, By Country, 2020–2027

7.4.7.2 Vagus Nerve Stimulator

Market Estimates & Forecast, By Region, 2020–2027

Market Estimates & Forecast, By Country, 2020–2027

7.4.7.3 Spinal Cord Stimulator

Market Estimates & Forecast, By Region, 2020–2027

Market Estimates & Forecast, By Country, 2020–2027

Chapter 8. Global Medical Bionic Implant/Artificial Organs Market, By Fixation

8.1 Introduction

8.2 Implantable

Market Estimates & Forecast, By Region, 2020–2027

Market Estimates & Forecast, By Country, 2020–2027

8.3 Externally Worn

Market Estimates & Forecast, By Region, 2020–2027

Market Estimates & Forecast, By Country, 2020–2027

Chapter 9. Global Medical Bionic Implant/Artificial Organs Market, By End-User

9.1 Introduction

9.2 Hospitals & Clinics

Market Estimates & Forecast, By Region, 2020–2027

Market Estimates & Forecast, By Country, 2020–2027

9.3 Research And Academic Institutes

Market Estimates & Forecast, By Region, 2020–2027

Market Estimates & Forecast, By Country, 2020–2027

9.4 Others

Chapter 10. Global Medical Bionic Implant/Artificial Organs Market, By Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 U.S.

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 U.K.

10.3.1.6 Rest Of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic Of Korea

10.4.6 Rest Of Asia Pacific

10.5 The Middle East & Africa

10.5.1 The Middle East

10.5.2 Africa

Chapter 11. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

Chapter 12. Company Profiles

12.1 Aleva Neurotherapeutics SA

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials

12.1.4 SWOT Analysis

12.2 Biocontrol Medical

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Biomet, Inc.

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Boston Scientific Corporation

12.4.1 Company Overview

12.4.2 Technology/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Cochlear Ltd.

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial Overview

12.5.4 Key Developments

12.6 Cyberonics, Inc.

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.7 Ekso Bionics

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 LivaNova PLC

12.8.1 Overview

12.8.2 Medical Bionic Implant/Artificial Organs Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 Medtronic, Inc.

12.9.1 Overview

12.9.2 Medical Bionic Implant/Artificial Organs Overview

12.9.3 Financials

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.10 NeuroPace, Inc.

12.10.1 Overview

12.10.2 Medical Bionic Implant/Artificial Organs Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.11 Orthofix International N.V.

12.11.1 Overview

12.11.2 Medical Bionic Implant/Artificial Organs Overview

12.11.3 Financials

12.11.4 Key Developments

12.11.5 SWOT Analysis

12.12 Ossur

12.12.1 Overview

12.12.2 Medical Bionic Implant/Artificial Organs Overview

12.12.3 Financials

12.12.4 Key Developments

12.12.5 SWOT Analysis

12.12 Second Sight Medical Products, Inc.

12.12.1 Overview

12.12.2 Medical Bionic Implant/Artificial Organs Overview

12.12.3 Financials

12.12.4 Key Developments

12.12.5 SWOT Analysis

12.14 St. Jude Medical, Inc.

12.14.1 Overview

12.14.2 Medical Bionic Implant/Artificial Organs Overview

12.14.3 Financials

12.14.4 Key Developments

12.14.5 SWOT Analysis

12.12 Others

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View Point

13.1.2 Unmet Needs Of The Market

13.2 Key Companies To Watch

13.3 Prediction Of The Medical Bionic Implant/Artificial Organs Industry

Chapter 14 Appendix

LIST OF TABLES

Table 1 Medical Bionic Implant/Artificial Organs Industry Synopsis, 2020–2027

Table 2 Medical Bionic Implant/Artificial Organs Market Estimates And Forecast, 2020–2027, (USD Million)

Table 3 Medical Bionic Implant/Artificial Organs Market, By Region, 2020–2027, (USD Million)

Table 4 Medical Bionic Implant/Artificial Organs Market, By Technology, 2020–2027, (USD Million)

Table 5 Medical Bionic Implant/Artificial Organs Market, By Product, 2020–2027, (USD Million)

Table 6 Medical Bionic Implant/Artificial Organs Market, By Fixation, 2020–2027, (USD Million)

Table 7 Medical Bionic Implant/Artificial Organs Market, By End-User, 2020–2027, (USD Million)

Table 8 North America Medical Bionic Implant/Artificial Organs Market, By Technology, 2020–2027, (USD Million)

Table 9 North America Medical Bionic Implant/Artificial Organs Market, By Product, 2020–2027, (USD Million)

Table 10 North America Medical Bionic Implant/Artificial Organs Market, By Fixation, 2020–2027, (USD Million)

Table 11 North America Medical Bionic Implant/Artificial Organs Market, By End-User, 2020–2027, (USD Million)

Table 12 U.S. Medical Bionic Implant/Artificial Organs Market, By Technology, 2020–2027, (USD Million)

Table 13 U.S. Medical Bionic Implant/Artificial Organs Market, By Product, 2020–2027, (USD Million)

Table 13 U.S. Medical Bionic Implant/Artificial Organs Market, By Fixation, 2020–2027, (USD Million)

Table 15 U.S. Medical Bionic Implant/Artificial Organs Market, By End-User, 2020–2027, (USD Million)

Table 16 Canada Medical Bionic Implant/Artificial Organs Market, By Technology, 2020–2027, (USD Million)

Table 17 Canada Medical Bionic Implant/Artificial Organs Market, By Product, 2020–2027, (USD Million)

Table 18 Canada Medical Bionic Implant/Artificial Organs Market, By Fixation, 2020–2027, (USD Million)

Table 19 Canada Medical Bionic Implant/Artificial Organs Market, By End-User, 2020–2027, (USD Million)

Table 20 South America Medical Bionic Implant/Artificial Organs Market, By Technology, 2020–2027, (USD Million)

Table 21 South America Medical Bionic Implant/Artificial Organs Market, By Product, 2020–2027, (USD Million

Table 22 South America Medical Bionic Implant/Artificial Organs Market, By Fixation, 2020–2027, (USD Million

Table 23 South America Medical Bionic Implant/Artificial Organs Market, By End-User, 2020–2027, (USD Million)

Table 24 Europe Medical Bionic Implant/Artificial Organs Market, By Technology, 2020–2027, (USD Million)

Table 25 Europe Medical Bionic Implant/Artificial Organs Market, By Product, 2020–2027, (USD Million)

Table 26 Europe Medical Bionic Implant/Artificial Organs Market, By Fixation, 2020–2027, (USD Million)

Table 27 Europe Medical Bionic Implant/Artificial Organs Market, By End-User, 2020–2027, (USD Million)

Table 28 Western Europe Medical Bionic Implant/Artificial Organs Market, By Technology, 2020–2027, (USD Million)

Table 29 Western Europe Medical Bionic Implant/Artificial Organs Market, By Product, 2020–2027, (USD Million)

Table 30 Western Europe Medical Bionic Implant/Artificial Organs Market, By Fixation, 2020–2027, (USD Million)

Table 31 Western Europe Medical Bionic Implant/Artificial Organs Market, By End-User, 2020–2027, (USD Million)

Table 32 Eastern Europe Medical Bionic Implant/Artificial Organs Market, By Technology, 2020–2027, (USD Million)

Table 33 Eastern Europe Medical Bionic Implant/Artificial Organs Market, By Product, 2020–2027, (USD Million)

Table 34 Eastern Europe Medical Bionic Implant/Artificial Organs Market, By Fixation, 2020–2027, (USD Million)

Table 35 Eastern Europe Medical Bionic Implant/Artificial Organs Market, By End-User, 2020–2027, (USD Million)

Table 36 Asia Pacific Medical Bionic Implant/Artificial Organs Market, By Technology, 2020–2027, (USD Million)

Table 37 Asia Pacific Medical Bionic Implant/Artificial Organs Market, By Product, 2020–2027, (USD Million)

Table 38 Asia Pacific Medical Bionic Implant/Artificial Organs Market, By Fixation, 2020–2027, (USD Million)

Table 39 Asia Pacific Medical Bionic Implant/Artificial Organs Market, By End-User, 2020–2027, (USD Million)

Table 40 Middle East & Africa Medical Bionic Implant/Artificial Organs Market, By Technology, 2020–2027, (USD Million)

Table 41 Middle East & Africa Medical Bionic Implant/Artificial Organs Market, By Product, 2020–2027, (USD Million)

Table 42 Middle East & Africa Medical Bionic Implant/Artificial Organs Market, By Fixation, 2020–2027, (USD Million)

Table 43 Middle East & Africa Medical Bionic Implant/Artificial Organs Market, By End-User, 2020–2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation For Medical Bionic Implant/Artificial Organs Market

Figure 3 Segmentation Market Dynamics For Medical Bionic Implant/Artificial Organs Market

Figure 4 Global Medical Bionic Implant/Artificial Organs Market Share, By Technology 2020

Figure 5 Global Medical Bionic Implant/Artificial Organs Market Share, By Product 2020

Figure 6 Global Medical Bionic Implant/Artificial Organs Market Share, By Fixation 2020

Figure 7 Global Medical Bionic Implant/Artificial Organs Market Share, By End-User, 2020

Figure 8 Global Medical Bionic Implant/Artificial Organs Market Share, By Region, 2020

Figure 9 North America Medical Bionic Implant/Artificial Organs Market Share, By Country, 2020

Figure 10 Europe Medical Bionic Implant/Artificial Organs Market Share, By Country, 2020

Figure 11 Asia Pacific Medical Bionic Implant/Artificial Organs Market Share, By Country, 2020

Figure 12 Middle East & Africa Medical Bionic Implant/Artificial Organs Market Share, By Country, 2020

Figure 13 Global Medical Bionic Implant/Artificial Organs Market: Company Share Analysis, 2020 (%)

Figure 13 Aleva Neurotherapeutics SA: Key Financials

Figure 15 Aleva Neurotherapeutics SA Segmental Revenue

Figure 16 Aleva Neurotherapeutics SA: Geographical Revenue

Figure 17 Biocontrol Medical: Key Financials

Figure 18 Biocontrol Medical: Segmental Revenue

Figure 19 Biocontrol Medical: Geographical Revenue

Figure 20 Biomet, Inc.: Key Financials

Figure 21 Biomet, Inc.: Segmental Revenue

Figure 22 Biomet, Inc.: Geographical Revenue

Figure 23 Boston Scientific Corporation: Key Financials

Figure 24 Boston Scientific Corporation: Segmental Revenue

Figure 25 Boston Scientific Corporation: Geographical Revenue

Figure 26 Cochlear Ltd.: Key Financials

Figure 27 Cochlear Ltd.: Segmental Revenue

Figure 28 Cochlear Ltd. Geographical Revenue

Figure 29 Cyberonics, Inc.: Key Financials

Figure 30 Cyberonics, Inc.: Segmental Revenue

Figure 31 Cyberonics, Inc.: Geographical Revenue

Figure 32 Ekso Bionics Inc.: Key Financials

Figure 33 Ekso Bionics Inc.: Segmental Revenue

Figure 34 Ekso Bionics Inc.: Geographical Revenue

Figure 35 LivaNova PLC: Key Financials

Figure 36 LivaNova PLC: Segmental Revenue

Figure 37 LivaNova PLC: Geographical Revenue

Figure 38 Medtronic, Inc.: Key Financials

Figure 39 Medtronic, Inc.: Segmental Revenue

Figure 40 Medtronic, Inc.: Geographical Revenue

Figure 41 NeuroPace, Inc.: Key Financials

Figure 42 NeuroPace, Inc.: Segmental Revenue

Figure 43 NeuroPace, Inc.: Geographical Revenue

Figure 44 Orthofix International N.V.: Key Financials

Figure 45 Orthofix International N.V.: Segmental Revenue

Figure 46 Orthofix International N.V.: Geographical Revenue